Insights

Given the incredible amounts of time and money invested in the specialty pharmacy market, it is important for key stakeholders to understand what medications are classified as specialty.read more

Come Jan. 31, Humira (adalimumab) will lose its exclusivity, opening the door for the eight approved adalimumab biosimilars to come to market by the end of 2023, which makes now a great time to discuss the differences between these biosimilar products.read more

The administration of infused drugs in the outpatient setting has traditionally been provided to patients in hospital-based and provider-based outpatient centers.read more

With the pharmacy resident recruiting season right around the corner, Tony Huke provides five tips to help you choose the best candidates for your program.read more

What started as a concept on the back of a napkin has grown into a full-fledged dedicated resource program geared towards helping providers enhance their pharmaceutical enterprise.read more

What started as a concept on the back of a napkin has grown into a full-fledged dedicated resource program geared towards helping providers enhance their pharmaceutical enterprise.read more

Drug Shortage Stewardship, a new concept that proposes a demand-side national approach, could be another tools to use when faced with the ever-present challenge of drug shortages.read more

Biosimilars are a hot topic in pharmacy right now, but will they really have an impact on the pharmaceutical industry? Senior Principal of Pharmacy Solutions Steven Lucio answers this question and more.read more

There have been many pharmaceutical changes in the cardiology service line in the past year – here’s what they are and why.read more

Some of the activities we enjoy so much during the summer can also put us at an increased risk of contracting tetanus. That’s why it’s important to be sure your tetanus vaccine is up to date.read more

Monkeypox has been declared a public health emergency. Here are some of the facts you should know.read more

Jane was diagnosed with advanced breast cancer. She had already received two therapies and was on a treatment that appeared to have decreased the size of her cancer per her most recent scan. When Jane arrived for her next infusion appointment, she learned that the drug was unavailable. She knew this drug was working for her and that other medications may be less effective and cause her hair to fall out again. Jane’s story is one of many examples of patients who continue to be impacted by drug shortages.read more